PDB Search results for query - Protein Data Bank Japan

PDB: 1 results

Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations
Descriptor:	Fibroblast growth factor receptor 2, N-{4-[(5P)-4-amino-5-{3-fluoro-4-[(4-methylpyrimidin-2-yl)oxy]phenyl}-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl}-2-methylpropanamide
Authors:	Valverde, R, Foster, L.
Deposit date:	2023-05-10
Release date:	2023-06-07
Last modified:	2023-10-25
Method:	X-RAY DIFFRACTION (3.79 Å)
Cite:	RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations. Cancer Discov, 13, 2023